Thiazolidinediones improve beta-cell function in Type 2 diabetic patients

被引：0
|
作者：
Gastaldelli, A
Mari, A
Miyazaki, Y
Matsuda, M
Ferrannini, E
DeFronzo, RA
机构：
[1] Univ Texas, Dept Med Diabet, San Antonio, TX 78285 USA
[2] CNR, Inst Clin Physiol, Metab Unit, I-56100 Pisa, Italy
[3] CNR, Inst Biomed Engn, Padua, Italy
[4] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
706
引用
收藏
页码：A255 / A256
页数：2
相关论文
共 50 条
  • [31] Effects of Dulaglutide and Trelagliptin on Beta-Cell Function in Patients with Type 2 Diabetes-The DUET-Beta Study
    Kondo, Yoshinobu
    Satoh, Shinobu
    Terauchi, Yasuo
    [J]. DIABETES, 2018, 67
  • [32] Effect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2 diabetic patients using oral antidiabetic drugs
    Ohta, Akio
    Kato, Hiroyuki
    Murayama, Katura
    Hashimoto, Eriko
    Murakami, Mariko
    Nishine, Ami
    Ohshige, Toshihiko
    Sada, Yoshiyuki
    Asai, Shiko
    Kawata, Takehiro
    Nagai, Yoshio
    Katabami, Takuyuki
    Tanaka, Yasushi
    [J]. ENDOCRINE JOURNAL, 2014, 61 (01) : 13 - 18
  • [33] Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
    Kunavisarut, Tada
    Sriussadaporn, Sutin
    Lertwattanarak, Raweewan
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 761 - 770
  • [34] RELATIONSHIPS BETWEEN DIABETES DURATION, METABOLIC CONTROL AND BETA-CELL FUNCTION IN A REPRESENTATIVE POPULATION OF TYPE-2 DIABETIC-PATIENTS IN SWEDEN
    CLAUSON, P
    LINNARSSON, R
    GOTTSATER, A
    SUNDKVIST, G
    GRILL, V
    [J]. DIABETIC MEDICINE, 1994, 11 (08) : 794 - 801
  • [35] Evaluation of islet beta cell function in newly diagnosed type 2 diabetic patients
    Li, Y.
    Zhu, D. L.
    Tian, H. M.
    Shi, L. X.
    Luo, Z. J.
    Yan, L.
    Zeng, L. Y.
    Zhou, Z. G.
    Yang, L. Y.
    Liu, J.
    Li, M.
    Weng, J. P.
    [J]. DIABETOLOGIA, 2006, 49 : 452 - 452
  • [36] Effect of nateglinide on beta-cell function in patients with mild Type 2 diabetes: a model analysis.
    Mari, A
    Gastaldelli, A
    Foley, J
    Pratley, R
    Ferrannini, E
    [J]. DIABETOLOGIA, 2003, 46 : A169 - A169
  • [37] IMPAIRED BETA-CELL FUNCTION BUT NOT SELECTIVE GLUCOSE INSENSITIVITY IN DIET-TREATED TYPE-2 DIABETIC SUBJECTS
    CAMPS, I
    SUTTON, P
    ASHCROFT, FM
    LEVY, JC
    [J]. DIABETOLOGIA, 1993, 36 : A74 - A74
  • [38] Rosiglitazone decreases insulin resistance and improves beta-cell function in patients with type 2 diabetes.
    Matthews, DR
    Bakst, A
    Weston, WM
    Hemyari, P
    [J]. DIABETOLOGIA, 1999, 42 : A228 - A228
  • [39] Myokine Regulation of Beta-Cell Mass and Function: Impact of Type 2 Diabetes
    Ciaraldi, Theodore P.
    Gomez, Daniela
    Baxi, Sunita
    Mudaliar, Sunder R.
    Henry, Robert R.
    [J]. DIABETES, 2013, 62 : A506 - A506
  • [40] Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes
    Kathleen A. Page
    Tamar Reisman
    [J]. Current Diabetes Reports, 2013, 13 : 252 - 260
12345